Skip to main content
SpringerLink
Log in

Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method

  • Research Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

Microsomes are an ideal medium to investigate cytochrome P450 (CYP450) enzyme-mediated drug metabolism. However, before microsomes are prepared, tissues can be stored for a long time. Studies about the stability of these enzymes in porcine hepatic and intestinal tissues upon storage are lacking. To be able to investigate CYP450 stability in microsomes prepared from these tissues, a highly sensitive and rapid HPLC-MS/MS method for the simultaneous determination of six CYP450 metabolites in incubation medium was developed and validated. The metabolites, paracetamol (CYP1A), 7-hydroxy-coumarin (CYP2A), 1-hydroxy-midazolam (CYP3A), 4-hydroxy-tolbutamide (CYP2C), dextrorphan (CYP2D), and 6-hydroxy-chlorzoxazone (CYP2E) were extracted with ethyl acetate at pH 1.0, followed by evaporation and separation on an Agilent Zorbax Eclipse Plus C18 column. The method was fully validated in a GLP-compliant laboratory according to European guidelines and was highly sensitive (LOQ = 0.25–2.5 ng/mL), selective, had good precision (RSD-within, 1.0–9.1%; RSD-between, 1.0–18.4%) and accuracy (within-run, 83.3–102%; between-run, 78.5–102%), and showed no relative signal suppression and enhancement. Consequently, this method was applied to study the stability of porcine hepatic and intestinal CYP450 isoenzymes when tissues were stored at − 80 °C. The results indicate that porcine CYP450 isoenzymes are stable in tissues at least up to 4 months when snap frozen and stored at − 80 °C. Moreover, the results indicate differences in porcine CYP450 stability compared to rat, rabbit, and fish CYP450, as observed by other research groups, hence stressing the importance to investigate the CYP450 stability of a specific species.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, et al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 1993;12(1):1–51.

    Article  CAS  Google Scholar 

  2. Lewis DFV. 57 varieties: the human cytochromes P450. Pharmacogenomics. 2004;5(3):305–18.

    Article  CAS  Google Scholar 

  3. Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J. 2006;8(1):101–11.

    Article  Google Scholar 

  4. Yuan R, Madani S, Wei X-X, Reynolds K, Huang S-M. Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos. 2002;30(12):1311–9.

    Article  CAS  Google Scholar 

  5. Yamazaki H, Inoue K, Turvy CG, Guengerich FP, Shimada T. Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome p450 enzymes. Drug Metab Dispos. 1997;25(2):168–74.

    CAS  Google Scholar 

  6. Förlin L, Andersson T. Storage conditions of rainbow trout liver cytochrome p-450 and conjugating enzymes. Comp Biochem Physiol. 1985;80(3):569–72.

    Google Scholar 

  7. Pearce RE, Mcintyre CJ, Madan A, Sanzgiri U, Draper AJ, Bullock PL, et al. Effects of freezing , thawing, and storing human liver microsomes on cytochrome P450 activity. Arch Biochem Biophys. 1996;331(2):145–69.

    Article  CAS  Google Scholar 

  8. Tredger JM, Chhabra RS. Preservation of various microsomal drug metabolizing components in tissue preparations from the livers, lungs and small intestines of rodents. Drug Metab Dispos. 1976;4(5):451–9.

    CAS  Google Scholar 

  9. Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism 1. J Pharmacol Exp Ther. 1997;283(3):1552–62.

    CAS  Google Scholar 

  10. Swindle MM, Makin A, Herron AJ, Clubb FJ, Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol. 2012;49(2):344–56.

    Article  CAS  Google Scholar 

  11. Bode G, Clausing P, Gervais F, Loegsted J, Luft J, Nogues V, et al. The utility of the minipig as an animal model in regulatory toxicology. J Pharmacol Toxicol Methods. 2010;62(3):196–220.

    Article  CAS  Google Scholar 

  12. Vaclavikova R, Soucek P, Svobodova L, Anzenbacher P, Simek P, Guengerich FP, et al. Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs. Drug Metab Dispos. 2004;32(6):666–74.

    Article  CAS  Google Scholar 

  13. Gasthuys E, Vandecasteele T, De Bruyne P, Vande Walle J, De Backer P, Devreese M, et al. the potential use of piglets as human pediatric surrogate for preclinical pharmacokinetic and pharmacodynamic drug testing. Curr Pharm Des. 2016;22:1–17.

  14. Anzenbacher P, Soucek P, Anzenbacherová E, Gut I, Hrubý K, Svoboda Z, et al. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes; comparison with human liver samples. Drug Metab Dispos. 1998;26(1):56–9.

    CAS  Google Scholar 

  15. Skaanild MT. Porcine cytochrome P450 and metabolism. Curr Pharm Des. 2006;12(11):1421–7.

    Article  CAS  Google Scholar 

  16. Matal J, Tunkov A, Iller M, Anzenbacherov E, Anzenbacher P. Isolation of two cytochrome P450 forms, CYP2A19 and CYP1A, from pig liver microsomes. J Vet Pharmacol Ther. 2009;32(5):470–6.

    Article  CAS  Google Scholar 

  17. Anzenbacherová E, Baranová J, Zuber R, Pechová A, Anzenbacher P, Soucek P, et al. Model systems based on experimental animals for studies on drug metabolism in man: (mini)pig cytochromes P450 3A29 and 2E1. Basic Clin Pharmacol Toxicol. 2004;95:244–5.

    Google Scholar 

  18. Puccinelli E, Gervasi PG, Longo V. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Curr Drug Metab. 2011;12(6):507–25.

    Article  CAS  Google Scholar 

  19. De Bock L, Boussery K, Colin P, De Smet J, T’jollyn H, Van Bocxlaer J. Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity. Talanta. 2012;89:209–16.

    Article  Google Scholar 

  20. Dinger J, Meyer MR, Maurer HH. Development and validation of a liquid-chromatography high-resolution tandem mass spectrometry approach for quantification of nine cytochrome P450 (CYP) model substrate metabolites in an in vitro CYP inhibition cocktail. Anal Bioanal Chem. 2014;406(18):4453–64.

    Article  CAS  Google Scholar 

  21. Lee KS, Kim SK. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug–drug interactions. J Appl Toxicol. 2013;33(2):100–8.

    Article  Google Scholar 

  22. Kim M-J, Kim H, Cha I-J, Park J-S, Shon J-H, Liu K-H, et al. High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2005;19(18):2651–8.

    Article  CAS  Google Scholar 

  23. Shi R, Ma B, Wu J, Wang T, Ma Y. Rapid and accurate liquid chromatography and tandem mass spectrometry method for the simultaneous quantification of ten metabolic reactions catalyzed by hepatic cytochrome P450 enzymes. J Sep Sci. 2015;38(19):3363–73.

    Article  CAS  Google Scholar 

  24. He F, Bi H, Xie Z, Zuo Z, Li J, Li X, et al. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. Rapid Commun Mass Spectrom. 2007;21:635–43.

    Article  CAS  Google Scholar 

  25. Li X, Chen X, Li Q, Wang L, Zhong D. Validated method for rapid inhibition screening of six cytochrome P450 enzymes by liquid chromatography-tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci. 2007;852:128–37.

    Article  CAS  Google Scholar 

  26. Walsky RL, Obach RS. Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 2004;32(6):647–60.

    Article  CAS  Google Scholar 

  27. Kostiainen R, Kauppila TJ. Effect of eluent on the ionization process in liquid chromatography–mass spectrometry. J Chromatogr A. 2009;1216:685–99.

    Article  CAS  Google Scholar 

  28. Goossens J, De Bock L, Osselaere A, Verbrugghe E, Devreese M, Boussery K, et al. The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs. Food Chem Toxicol. 2013;57:54–6.

    Article  CAS  Google Scholar 

  29. Guerre P, Eeckhoutte C, Burgat V, Galtier P. The effects of T-2 toxin exposure on liver drug metabolizing enzymes in rabbit. Food Addit Contam. 2007;17:1019–26.

    Article  Google Scholar 

  30. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice–drug interactions. Br J Clin Pharmacol. 1998;46:101–10.

    Article  CAS  Google Scholar 

  31. Bradford MM. A rapid and sensitive method for the quantitation microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 1976;72:248–54.

    Article  CAS  Google Scholar 

  32. Commision Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eur Communities. 2002;L221:8–36.

  33. Knecht J, Stork G. Prozentuales und logarithmisches Verfahren zur Berechnung von Eichkurven. Fresenius’ Z Anal Chem. 1974;99(270):97–9.

  34. Wilson ZE, Rostami-Hodjegan A, Burn JL, Tooley A, Boyle J, Ellis SW, et al. Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Br J Clin Pharmacol. 2003;56(4):433–40.

    Article  CAS  Google Scholar 

  35. Osselaere A, De Bock L, Eeckhaut V, De Backer P, Van Bocxlaer J, Boussery K, et al. Hepatic and intestinal CYP3A expression and activity in broilers. J Vet Pharmacol Ther. 2013;36:588–93.

  36. Hewavitharana AK. Matrix matching in liquid chromatography–mass spectrometry with stable isotope labelled internal standards—is it necessary? J Chromatogr A. 2011;1218(2):359–61.

    Article  CAS  Google Scholar 

  37. Yao M, Dai M, Liu Z, Cui W, Li D, Zhang H, et al. mRNA expression profiles of P450 3A enzymes in the liver and small intestine of the domestic pig. Res Vet Sci. 2012;93(1):360–5.

    Article  CAS  Google Scholar 

  38. Guruprasad K, Reddy BVB, Pandit WM. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. 1991;4(2):155–61.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the Ghent University Special Research Fund grant BOF. DOC.2015.0075.

Author information

Authors and Affiliations

  1. Laboratory of Pharmacology and Toxicology, Department of Pharmacology, Toxicology and Biochemistry, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820, Merelbeke, Belgium

    Wim Schelstraete, Mathias Devreese & Siska Croubels

Authors
  1. Wim Schelstraete
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mathias Devreese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Siska Croubels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siska Croubels.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Welfare of animals

All procedures followed were in accordance to the ethical standards of the ethical committee of the Faculties of Veterinary Medicine and Bioscience Engineering of Ghent University. The pigs were subject to the approval with number EC2015_113.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schelstraete, W., Devreese, M. & Croubels, S. Storage stability study of porcine hepatic and intestinal cytochrome P450 isoenzymes by use of a newly developed and fully validated highly sensitive HPLC-MS/MS method. Anal Bioanal Chem 410, 1833–1843 (2018). https://doi.org/10.1007/s00216-017-0839-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-017-0839-z

Keywords

Search

Navigation